Adaptive Biotechnologies Corp Earnings

Adaptive Biotechnologies Corp’s revenue jumped 51.04% since last year same period to $71.68Mn in the Q4 2025. On a quarterly growth basis, Adaptive Biotechnologies Corp has generated -23.72% fall in its revenue since last 3-months.

Adaptive Biotechnologies Corp’s net profit jumped 59.7% since last year same period to $-13.58Mn in the Q4 2025. On a quarterly growth basis, Adaptive Biotechnologies Corp has generated -242.25% fall in its net profits since last 3-months.

Adaptive Biotechnologies Corp’s net profit margin jumped 73.32% since last year same period to -18.94% in the Q4 2025. On a quarterly growth basis, Adaptive Biotechnologies Corp has generated -286.49% fall in its net profit margins since last 3-months.

Adaptive Biotechnologies Corp’s earning per share (EPS) estimates for the current quarter stand at -0.17 - a 3% jump from last quarter’s estimates.

Adaptive Biotechnologies Corp’s earning per share (EPS) estimates for the current year stand at -0.17.

Adaptive Biotechnologies Corp’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Adaptive Biotechnologies Corp has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.